The Patent Finder

Beta Cat Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Beta Cat Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to Beta Cat Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,238,030Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia.
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,725,473Anthracene-9, 10-dione dioxime compound prodrugs and their uses
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,963,475Anthracene-9, 10-dione dioxime compound prodrugs and their uses
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited